August 10, 2023 • 4:10 pm EDT TerrAscend Reports Second Quarter 2023 Record Net Revenue of $72.1 Million, an Increase of 12.7% Year-Over-Year and 3.9% Sequentially, Representing its 7th Consecutive Quarter of Sequential Revenue Growth
August 1, 2023 • 8:42 am EDT TerrAscend Preannounces Strong Second Quarter 2023 Revenue and Gross Margins and Provides Full Year Guidance
July 10, 2023 • 7:30 am EDT TerrAscend Reaches Four Dispensary Cap in Maryland with Closing of Herbiculture Acquisition
June 30, 2023 • 5:02 pm EDT TerrAscend Increases Footprint in Maryland to Four Dispensaries with Agreement to Acquire Herbiculture, Transaction Already Approved by Maryland Regulator
June 30, 2023 • 3:56 pm EDT TerrAscend Closes on Third Dispensary Acquisition in Maryland Ahead of Adult-Use Launch
June 30, 2023 • 7:59 am EDT TerrAscend Announces $37 Million Paydown of Senior Secured Term Loan in Pennsylvania
June 28, 2023 • 2:35 pm EDT TerrAscend Closes on Acquisition of Top Performing Maryland Dispensary, Peninsula Alternative Health